Porokeratoses: an update on pathogenesis and treatment

Area of Science:

• Dermatology
• Genetics
• Biochemistry

Background:

• Porokeratoses (PK) are uncommon dermatoses with abnormal epidermal differentiation.
• They stem from a disorder in the mevalonate metabolic pathway.
• PK exhibits diverse clinical subtypes and a characteristic histopathologic finding, the cornoid lamella.

Purpose of the Study:

• To elucidate the pathogenesis of Porokeratoses.
• To explore the genetic basis and inheritance patterns of PK.
• To evaluate current and novel therapeutic strategies for PK.

Main Methods:

• Genetic analysis to identify pathogenic variants in the mevalonate pathway.
• Histopathological examination to confirm the cornoid lamella.
• Clinical evaluation of treatment efficacy for various PK subtypes.

Main Results:

• Pathogenesis linked to germline variants in the mevalonate pathway, requiring a second hit.
• PK is dominantly inherited but recessively expressed.
• New topical treatments (statins and cholesterol) demonstrate improved efficacy over older methods.

Conclusions:

• The mevalonate metabolic pathway is central to PK pathogenesis.
• Understanding the genetic basis informs inheritance patterns and management.
• Novel topical treatments offer more consistent efficacy for Porokeratoses.